|
(P1083) |
Treatment of atrial fibrillation in Germany - a longitudinal observational study using routine claims data |
| |
|
M. Rauchhaus, S. Kloss, E. Basic, T. Windeck (Berlin) |
|
(P1084) |
The impact of overt vascular disease in patients with comorbid type-2 diabetes and hypertension: data from the DIALOGUE registry |
| |
|
A. K. Gitt, D. Tschöpe, P. Bramlage, C. Koch, T. Ouarrak, R. E. Schmieder (Ludwigshafen, Bad Oeynhausen, Mahlow, Nürnberg, Erlangen) |
|
(P1085) |
QT interval prolongation in obesity and metabolic syndrome: myth or fact? |
| |
|
C. Strack, D. Feßmann, S. Fenk, M. Mohr, J. Zeller, U. Hubauer, L. S. Maier, M. Fischer, A. Bäßler (Regensburg) |
|
(P1086) |
Risikofaktorenprofil bei Patienten mit Herzinfarkt: Rauchen bei jüngeren Patienten |
| |
|
H. Theres, B. Maier, S. Behrens, R. Schoeller, H. Schühlen , BHIR (Berlin) |
|
(P1087) |
Hoch-sensitiver Score zur globalen Erfassung leitliniengerecht eingestellter kardiovaskulärer Risikofaktoren nach Myokardinfarkt. Methodik und erste Daten der IPP-Studie. |
| |
|
H. Wienbergen, S. Seide, J. Stehmeier, S. Bünger, T. Härle, J. Meyer, H. Haase, K. Krämer, S. Michel, A. Elsässer, R. Hambrecht für die Studiengruppe IPP-Studie (Bremen, Oldenburg) |
|
(P1088) |
Six percent of young males ECGs are automatically detected as abnormal when applying the Seattle Criteria to a general population |
| |
|
R. Abächerli, R. Kobza, C. Schmied, F. Frei (Basel, Luzern 16, Zürich, Ittigen, CH) |
|
(P1089) |
Long-term intense endurance exercise is not associated with subclinical vascular organ damage - a comprehensive analysis |
| |
|
A. Preßler, C. Suchy, T. Friedrichs, S. Dallinger, M. Dinic, M. Halle, J. Scherr (München) |
|
(P1090) |
Differentielle Effekte von Ausdauertraining, Intervalltraining und Krafttraining auf Telomeraseaktivität und Seneszenzmarker in zirkulierenden mononukleären Zellen |
| |
|
C. Werner, A. Hecksteden, J. Zundler, M. Böhm, T. Meyer, U. Laufs (Homburg/Saar, Saarbrücken) |
|
(P1091) |
Platelet-bound Cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction |
| |
|
P. Seizer, C. Fuchs, S. v. Ungern-Sternberg, D. Heinzmann, M. Gawaz, A. May, T. Geisler (Tübingen, Memmingen) |
|
(P1092) |
GLP-1 is increased in response to an inflammatory stimulus in humans which is best predicted by IL6 |
| |
|
C. Lebherz, K. Piotrowski, F. Kahles, M. Vogeser, A. Foldenauer, E. Kilger, N. Marx, K. Parhofer, M. Lehrke (Aachen, München) |
|
(P1093) |
Genetic deletion of the soluble epoxide hydrolase protects mice against obesity-induced type-2 diabetes |
| |
|
N. Mangels, K. Awwad, I. Fleming (Frankfurt am Main) |
|
(P1094) |
Low LDL-cholesterol target achievement in statin-treated patients in clinical practice in China and Europe: Results of the Dyslipidemia International Study (DYSIS) |
| |
|
A. K. Gitt, B. M. Ambegaonkar, M. Horack, P. Brudi, D. Lautsch, J. Ferrieres, D.-Y. Hu , DYSIS Investigators (Ludwigshafen; Whitehouse Station, US; Toulouse, FR; Beijing, CN) |
|
(P1095) |
Statin treated patients at very high cardiovascular risk: Are the majority close to LDL-C <70 mg/dl? - Results of DYSIS I |
| |
|
A. K. Gitt, D. Lautsch, M. Horack, V. Ashton, P. Brudi, B. M. Ambegaonkar, J. Ferrieres , DYSIS Investigators (Ludwigshafen; Whitehouse Station, US; Toulouse, FR) |
|
(P1096) |
Unexpected High Prevalence of Possible and Probable FH in Clinical Practice – Results of DYSIS I |
| |
|
A. K. Gitt, L. Tokgözoglu, D. Lautsch, M. Horack, B. M. Ambegaonkar, P. Brudi, J. Ferrieres , DYSIS Investigators (Ludwigshafen; Ankara, TR; Whitehouse Station, US; Toulouse, FR) |
|
(P1097) |
Functional iron deficiency deteriorates clinical and functional outcome in patients with acute ischemic stroke |
| |
|
N. Scherbakov, M. Knops, A. Sandek, N. Ebner, M. Valentova, S. von Haehling, S. D. Anker, W. Döhner (Berlin, Göttingen) |